When compared to next-generation sequencing (NGS) technology, Demuth et al. [40] concluded in a study measuring KRAS mutations in ctDNA of CRC patients using ddPCR and NGS that both methods have high concordance to tumor genotype (79% and 89%). Here, KRAS is linked to neoplasm.